Northwest Biotherapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $1.0M | $-52.7M | $179.1M |
| FY2022 | $1.7M | $-67.2M | $-105.0M |
| FY2023 | $1.9M | $-55.5M | $-62.6M |
| FY2024 | $1.4M | $-66.5M | $-83.8M |
| FY2025 | $1.4M | $-59.9M | $-60.2M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $1.0M | $-52.7M | $179.1M |
| FY2022 | $1.7M | $-67.2M | $-105.0M |
| FY2023 | $1.9M | $-55.5M | $-62.6M |
| FY2024 | $1.4M | $-66.5M | $-83.8M |
| FY2025 | $1.4M | $-59.9M | $-60.2M |